LHRH Agonists for Prostate Cancer Treatment
The speaker identifies Leuprolide as an established peptide used in oncology, specifically for treating prostate cancer. It functions as a gonadotropin-releasing hormone (GnRH) agonist and is described as a form of 'chemical castration.' The transcript notes that this treatment has been available for some time and is considered very effective.
GnRH Agonists as Chemical Castration Therapy
Gonadotropin-releasing hormone (GnRH) agonists, specifically Leuprolide, are established peptide therapies used in oncology for prostate cancer. They function by inducing 'chemical castration' to suppress testosterone-driven tumor growth.